Page 2580 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 158 Hematologic Aspects of Parasitic Diseases 2303

(Ancylostoma duodenale) of blood each day. These infections are a Dhabangi A, Ainomugisha B, Cserti-Gazdewich C, et al: B-type natriuretic
common contributing factor to iron deficiency anemia in children, peptide and plasma hemoglobin levels following transfusion of shorter-
in whom infection is acquired by eating or walking barefoot on storage versus longer-storage red blood cells: results from the TOTAL
larva-infected soil. The disease is usually diagnosed by finding randomized trial. Am Heart J 183:129, 2016.
excreted eggs in stool samples, and treatment is with albendazole. Drakesmith H, Prentice AM: Hepcidin and the iron-infection axis. Science
338:768–772, 2012.
Genovese G, Friedman DJ, Ross MD, et al: Association of trypanolytic ApoL1
Tapeworm Infection variants with kidney disease in African Americans. Science 329:841, 2010.
Gething PW, Casey DC, Weiss DJ, et al: Mapping Plasmodium falciparum
The fish tapeworm (Diphyllobothrium latum) is a rare cause of vitamin mortality in Africa between 1990 and 2015. N Engl J Med 375:2435,
B 12 deficiency. This tapeworm is transmitted in the Far East by eating 2016.
raw or partially cooked fish. Infection has to be extensive and causes Gubernot DM, Lucey CT, Lee KC, et al: Babesia infection through blood
vitamin B 12 deficiency; however, such cases are rare, even in endemic transfusions: reports received by the US Food and Drug Administration,
areas. 1997–2007. Clin Infect Dis 48:25, 2009.
Hoffman SL, Vekemans J, Richie TL, et al: The march toward malaria vac-
cines. Am J Prev Med 49(6 Suppl 4):S319, 2015.
Schistosomiasis Jimenez-Marco T, Fisa R, Girona-Llobera E, et al: Transfusion-transmitted
leishmaniasis: a practical review. Transfusion 56(Suppl 1):S45, 2016.
Schistosoma haematobium causes blood loss in urine. Infection is Lalloo DG, Shingadia D, Bell DJ, et al: UK malaria treatment guidelines
acquired by swimming in freshwater, where cercariae from the 2016. J Infect 72:635–649, 2016.
infected snail host enter the skin and migrate to the blood vessels of Langhorne J, Duffy PE: Expanding the antimalarial toolkit: targeting host-
the bladder. Chronic blood loss is a cause of iron deficiency anemia parasite interactions. J Exp Med 213:143–153, 2016.
in children in endemic areas, but infection is likely to be diagnosed Leiby DA: Transfusion-transmitted Babesia spp.: bull’s-eye on Babesia microti.
at an early stage in travelers because of the striking symptoms of Clin Microbiol Rev 24:14, 2011.
painless hematuria. Treatment is with praziquantel. Lindoso JA, Cunha MA, Queiroz IT, et al: Leishmaniasis-HIV coinfection:
current challenges. HIV AIDS (Auckl) 8:147–156, 2016.
Maitland K, Kiguli S, Opoka RO, et al: Mortality after fluid bolus in African
FUTURE DIRECTIONS children with severe infection. N Engl J Med 364:2483, 2011.
Marsh K, Forster D, Waruiru C, et al: Indicators of life-threatening malaria
Parasitic diseases present many problems for global heath. They cause in African children. N Engl J Med 332:1399, 1995.
a wide spectrum of hematologic abnormalities, and in endemic areas, Millar SB, Cox-Singh J: Human infections with Plasmodium knowlesi—
a broad knowledge of the parasitic disease is vital for everyday prac- zoonotic malaria. Clin Microbiol Infect 21:640, 2015.
tice. In nonendemic areas, there are a few situations where the Moreira CM, Abo-Shehada M, Price RN, et al: A systematic review of sub-
diagnosis or management of these diseases may fall within the remit microscopic Plasmodium vivax infection. Malar J 14:360, 2015.
of hematologists and hematology laboratories, particularly malaria Morrell CN: Understanding platelets in malaria infection. Curr Opin Hematol
and the diagnosis of anemia, cytopenias, eosinophilia, and hepato- 21:445–449, 2014.
splenomegaly. Here, a high index of suspicion is often needed for the Mungai M, Tegtmeier G, Chamberland M, et al: Transfusion-transmitted
diagnosis to be made. A good travel history is crucial to establishing malaria in the United States from 1963 through 1999. N Engl J Med
exposure to parasitic disease and to prompt the search for the appro- 344:1973, 2001.
priate organisms. Several parasitic diseases pose a threat for the safe Sahu PK, Satpathi S, Behera PK, et al: athogenesis of cerebral malaria: new
supply of blood, and the problems of screening of these infections diagnostic tools, biomarkers, and therapeutic approaches. Front Cell Infect
are far from solved. Beyond everyday practice, the pathophysiology Microbiol 5:75, 2015.
and prevention of these diseases pose major challenges for biomedical Satchwell TJ: Erythrocyte invasion receptors for Plasmodium falciparum: new
research and public health. and old. Transfus Med 26:77–88, 2016.
Simarro PP, Cecchi G, Paone M, et al: The atlas of human African trypano-
somiasis: a contribution to global mapping of neglected tropical diseases.
SUGGESTED READINGS Int J Health Geogr 9:57, 2010.
Soriano-Arandes A, Angheben A, Serre-Delcor N, et al: Control and manage-
Ashley EA, Recht J, White NJ: Primaquine: the risks and the benefits. Malar ment of congenital Chagas disease in Europe and other non-endemic
J 13:418, 2014. countries: current policies and practices. Trop Med Int Health 5:590–596,
Babokhov P, Sanyaolu AO, Oyibo WA, et al: A current analysis of chemo- 2016.
therapy strategies for the treatment of human African trypanosomiasis. Steinmann P, Stone CM, Sutherland CS, et al: Contemporary and emerg-
Pathog Glob Health 5:242, 2013. ing strategies for eliminating human African trypanosomiasis due to
Bailey JW, Williams J, Bain BJ, et al: Guideline: the laboratory diagnosis of Trypanosoma brucei gambiense: review. Trop Med Int Health 6:707–718,
malaria. Br J Haematol 163:573, 2013. 2015.
Bennett JE, Dolin R, Blaser MJ: Mandell, Douglas, and Bennett’s principles and Sundar S, Singh A: Recent developments and future prospects in the treat-
practice of infectious diseases, ed 8, London, 2014, Churchill Livingstone. ment of visceral leishmaniasis. Ther Adv Infect Dis 3:98–109, 2016.
Bern C: Antitrypanosomal therapy for chronic Chagas’ disease. N Engl J Med Vannier E, Krause PJ: Human babesiosis. N Engl J Med 366:2397, 2012.
364:2527, 2011. Wendel S: Transfusion transmitted Chagas disease: is it really under control?
Brun R, Blum J, Chappuis F, et al: Human African trypanosomiasis. Lancet Acta Trop 115:28, 2010.
375:148, 2011. Woodrow CJ, White NJ: The clinical impact of artemisinin resistance in
Clark MA, Goheen MM, Cerami C: Influence of host iron status on Plasmo- Southeast Asia and the potential for future spread. FEMS Microbiol Rev
dium falciparum infection. Front Pharmacol 5:84, 2014. 41:34, 2017.
Copeland NK, Aronson NE: Leishmaniasis: treatment updates and clinical World Health Organization: Control of the leishmaniases. World Health
practice guidelines review. Curr Opin Infect Dis 28:426–437, 2015. Organ Tech Rep Ser 949:1, 2010.
Coura JR, Borges-Pereira J: Chagas disease: 100 years after its discovery. A
systemic review. Acta Trop 115:5, 2010.
Cox FE: History of human parasitology. Clin Microbiol Rev 15:595, 2002. REFERENCES
Croft SL, Olliaro P: Leishmaniasis chemotherapy—challenges and opportu-
nities. Clin Microbiol Infect 17:1478, 2010. For the complete list of references, log on to www.expertconsult.com.